State of Wyoming’s TG Therapeutics TGTX Stock Holding History

State of Wyoming’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.86K	Buy	+52	New	+$2.13K	﹤0.01%	1855
2025 Q1	–	Sell	-251	Closed	-$7.55K	–	1843
2024 Q4	$7.55K	Buy	+251	New	+$7.2K	﹤0.01%	1541
2022 Q1	–	Sell	-223	Closed	-$4K	–	2016
2021 Q4	$4K	Sell	223 -55	-20%	-$1.43K	﹤0.01%	1740
2021 Q3	$9K	Sell	278 -201	-42%	-$6.22K	0.01%	1044
2021 Q2	$19K	Buy	479 +283	+144%	+$11.1K	0.01%	936
2021 Q1	$9K	Buy	+196	New	+$9.42K	0.01%	400

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

State of Wyoming's TGTX Position: Q2 2026 in Review

State of Wyoming opened a new position in TG Therapeutics (TGTX) in Q2 2026: 52 shares worth $2.86K. The stake represents ﹤0.01% of the portfolio and ranks #1855 among its holdings. This is a return to the name: State of Wyoming previously reported a position in TGTX as recently as Q4 2024.

State of Wyoming first reported a position in TGTX in Q1 2021 and has held it in 6 quarters since. The position peaked at $19K in Q2 2021. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

State of Wyoming held 52 shares of TG Therapeutics worth $2.86K as of Q2 2026.
TG Therapeutics was a new State of Wyoming position in Q2 2026.
TG Therapeutics made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1855 holding.
State of Wyoming first reported a position in TG Therapeutics in Q1 2021 and has held it in 6 quarters since.
State of Wyoming's TG Therapeutics position peaked at $19K in Q2 2021.
431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.